Laura Contreras-Espinosa
Overview
Explore the profile of Laura Contreras-Espinosa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
229
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gonzalez-Woge M, Contreras-Espinosa L, Garcia-Gordillo J, Aguilar-Villanueva S, Bargallo-Rocha E, Cabrera-Galeana P, et al.
Int J Mol Sci
. 2024 Aug;
25(15).
PMID: 39125649
lncRNAs are noncoding transcripts with tissue and cancer specificity. Particularly, in breast cancer, lncRNAs exhibit subtype-specific expression; they are particularly upregulated in luminal tumors. However, no gene signature-based laboratory tests...
2.
Dominguez-Ortiz J, Alvarez-Gomez R, Montiel-Manriquez R, Cedro-Tanda A, Alcaraz N, Castro-Hernandez C, et al.
Int J Mol Sci
. 2024 Jun;
25(12).
PMID: 38928478
Hereditary breast and ovarian cancer (HBOC) syndrome is a genetic condition that increases the risk of breast cancer by 80% and that of ovarian cancer by 40%. The most common...
3.
Jimenez-Trejo F, Tapia-Rodriguez M, Arriaga-Canon C, Herrera L, Contreras-Espinosa L, Jimenez-Garcia K
Front Neurosci
. 2023 Sep;
17:1200370.
PMID: 37694111
Surely, Vittorio Erspamer, discoverer of Enteramine in 1935, and Irvine Page, Maurice M. Rapport and Arda Green, discoverers of Serotonin in 1948, never imagined the biological importance that this fundamental...
4.
Arriaga-Canon C, Contreras-Espinosa L, Aguilar-Villanueva S, Bargallo-Rocha E, Garcia-Gordillo J, Cabrera-Galeana P, et al.
Int J Mol Sci
. 2023 Apr;
24(8).
PMID: 37108589
Given their tumor-specific and stage-specific gene expression, long non-coding RNAs (lncRNAs) have demonstrated to be potential molecular biomarkers for diagnosis, prognosis, and treatment response. Particularly, the lncRNAs and serve as...
5.
Arriaga-Canon C, Contreras-Espinosa L, Rebollar-Vega R, Montiel-Manriquez R, Cedro-Tanda A, Garcia-Gordillo J, et al.
Int J Mol Sci
. 2022 Oct;
23(19).
PMID: 36232363
SARS-CoV-2 is a coronavirus family member that appeared in China in December 2019 and caused the disease called COVID-19, which was declared a pandemic in 2020 by the World Health...
6.
Contreras-Espinosa L, Alcaraz N, de la Rosa-Velazquez I, Diaz-Chavez J, Cabrera-Galeana P, Rebollar-Vega R, et al.
J Mol Diagn
. 2021 Aug;
23(10):1306-1323.
PMID: 34358678
Breast cancer is one of the leading causes of mortality in women worldwide, and neoadjuvant chemotherapy has emerged as an option for the management of locally advanced breast cancer. Extensive...
7.
Herrera L, Hidalgo-Miranda A, Reynoso-Noveron N, Meneses-Garcia A, Mendoza-Vargas A, Reyes-Grajeda J, et al.
Int J Infect Dis
. 2021 Feb;
105:83-90.
PMID: 33581365
Objectives: The aim of this study was to investigate the feasibility of saliva sampling as a non-invasive and safer tool to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and...
8.
Bautista-Sanchez D, Arriaga-Canon C, Pedroza-Torres A, De La Rosa-Velazquez I, Gonzalez-Barrios R, Contreras-Espinosa L, et al.
Mol Ther Nucleic Acids
. 2020 Apr;
20:409-420.
PMID: 32244168
MicroRNAs are small noncoding transcripts that posttranscriptionally regulate gene expression via base-pairing complementarity. Their role in cancer can be related to tumor suppression or oncogenic function. Moreover, they have been...